Xtant Medical Holdings (XTNT) Common Equity (2010 - 2025)

Xtant Medical Holdings (XTNT) has reported Common Equity for 16 consecutive years, with $51.0 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Common Equity rose 18.6% year-over-year to $51.0 million in Q4 2025; TTM through Dec 2025 was $51.0 million, a 18.6% increase from a year earlier, with the FY2025 full-year figure at $51.0 million, up 18.6% from the prior year.
• Common Equity was $51.0 million for Q4 2025 at Xtant Medical Holdings, up from $50.4 million in the prior quarter.
• Over five years, Common Equity peaked at $54.7 million in Q3 2023 and troughed at $28.1 million in Q2 2022.
• A 5-year average of $40.0 million and a median of $38.6 million in 2022 frame the typical range for Common Equity.
• The widest YoY moves for Common Equity: up 172.31% in 2021, down 56.48% in 2021.
• Over 5 years, Common Equity stood at $30.9 million in 2021, then climbed by 10.65% to $34.2 million in 2022, then jumped by 50.27% to $51.3 million in 2023, then declined by 16.33% to $43.0 million in 2024, then grew by 18.6% to $51.0 million in 2025.
• The last three Common Equity figures came in at $51.0 million (Q4 2025), $50.4 million (Q3 2025), and $48.5 million (Q2 2025), per Business Quant data.